Efficacy of topotecan in pretreated metastatic poorly differentiated extrapulmonary neuroendocrine carcinoma
نویسندگان
چکیده
منابع مشابه
Efficacy of topotecan in pretreated metastatic poorly differentiated extrapulmonary neuroendocrine carcinoma
Therapeutic options for metastatic poorly differentiated neuroendocrine carcinoma (NEC) after prior platinum-based chemotherapy are limited. Topotecan is an approved second-line chemotherapy for small cell lung cancer (SCLC). NEC is often considered to show a biological behavior similar to SCLC. The aim of this study was to analyze the efficacy of topotecan in pretreated metastatic NEC patients...
متن کاملMetastatic pancreatic poorly differentiated neuroendocrine carcinoma: current treatment considerations.
Pancreatic poorly differentiated neuroendocrine tumors (PDNETs) are a subtype of neuroendocrine tumors (NETs) that are clinically distinguished by their very rapid growth. They are immunohistochemically diagnosed by having a higher Ki-67 cancer cell staining percentage when compared with well or intermediately differentiated NETs. These tumors are typically treated in the same manner as small c...
متن کاملTreatment of poorly differentiated neuroendocrine carcinoma of the pancreas.
Poorly differentiated neuroendocrine carcinoma is a rare malignancy that remains a challenge to treat. Poorly differentiated neuroendocrine carcinoma occurs at an incidence of 2% annually in United States. The current standard of care is based largely upon retrospective data. There remains a need for large prospective cooperative group trials in the management of poorly differentiated neuroendo...
متن کاملpoorly-differentiated bronchial carcinoma
The production of serotonin (5-hydroxtryptamine) and certain related metabolites by tumours associated with the clinical carcinoid syndrome has now been well established. Many of the reported cases have concerned carcinoid tumours of the intestinal tract (Thorson, 1958 ; Macfarlane, Dalgliesh, Dutton, Lennox, Nyhus, and Smith, 1956) but tumours histologically resembling carcinoids, and also app...
متن کاملA Case Report of a Poorly Differentiated Neuroendocrine Carcinoma Diagnosed in the Bone Marrow
Neuroendocrine tumors are relatively rare tumors with an incidence of 5.25 per 100,000 per year in the United States [1]. They range from well differentiated slow growing tumors to highly aggressive poorly differentiated tumors [2]. The common primary sites of neuroendocrine carcinomas are lung and gastrointestinal tract. However, 3-5 % of these tumors are diagnosed as metastatic disease with u...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer Medicine
سال: 2016
ISSN: 2045-7634
DOI: 10.1002/cam4.807